Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol in Hyperdynamic Vasoplegic Septic Shock
NCT02609152Phase 3Withdrawn
- Sponsor
- CHU Nîmes
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of esmolol in septic shock, sponsored by CHU Nîmes. Planned start Jul 2016; status: withdrawn.
02
Drugs
esmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02609152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609152.